Follow
Maarten Slagter
Title
Cited by
Cited by
Year
Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids
KK Dijkstra, CM Cattaneo, F Weeber, M Chalabi, J van de Haar, ...
Cell 174 (6), 1586-1598. e12, 2018
8432018
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ...
Nature medicine 25 (6), 920-928, 2019
7382019
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
DJ McGrail, PG Piliť, NU Rashid, L Voorwerk, M Slagter, M Kok, ...
Annals of Oncology 32 (5), 661-672, 2021
7122021
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
R Mezzadra, C Sun, LT Jae, R Gomez-Eerland, E De Vries, W Wu, ...
Nature 549 (7670), 106-110, 2017
5982017
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
W Scheper, S Kelderman, LF Fanchi, C Linnemann, G Bendle, ...
Nature medicine 25 (1), 89-94, 2019
5132019
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
MD Wellenstein, SB Coffelt, DEM Duits, MH van Miltenburg, M Slagter, ...
Nature 572 (7770), 538-542, 2019
4052019
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ...
Cell 183 (3), 818-834. e13, 2020
3592020
Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): final response data stage I and first translational data.
M Kok, L Voorwerk, H Horlings, K Sikorska, K van der Vijver, M Slagter, ...
Journal of Clinical Oncology 36 (15_suppl), 1012-1012, 2018
472018
Contact-dependent killing by cytotoxic T lymphocytes is insufficient for EL4 tumor regression in vivo
RJ Beck, M Slagter, JB Beltman
Cancer research 79 (13), 3406-3416, 2019
302019
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.
L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ...
Nature medicine 25 (7), 1175-1175, 2019
132019
Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay
DJ McGrail, PG Piliť, NU Rashid, L Voorwerk, M Slagter, M Kok, ...
Annals of Oncology 33 (11), 1204-1206, 2022
42022
Spatial proximity of CD8 T cells to tumor cells as an independent biomarker for response to anti-PD-1 therapy.
M Slagter, EA Rozeman, H Ding, JM Versluis, M Valenti, D Peters, ...
Journal of Clinical Oncology 38 (15_suppl), 10038-10038, 2020
32020
Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironment
ME Hoekstra, M Slagter, J Urbanus, M Toebes, N Slingerland, I de Rink, ...
Cancer Cell 42 (1), 157-167. e9, 2024
22024
Reply to:‘Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab†…
DJ McGrail, PG Piliť, NU Rashid, L Voorwerk, M Slagter, M Kok, ...
Annals of Oncology 32 (9), 1194-1197, 2021
22021
31 Loss of P53 drives systemic neutrophilic inflammation in breast cancer
M Wellenstein, S Coffelt, D Duits, M Van Miltenburg, M Slagter, I De Rink, ...
ESMO Open 3, A14, 2018
12018
Urbanus
ME Hoekstra, M Slagter
Toebes, M., Slingerland, N., Rink, I. de,… Schumacher, TN, 157-167, 2024
2024
Lack of detectable neoantigen depletion in treatment-naÔve cancers
M Slagter, LF Fanchi, MM van Buuren, A Velds, G Bounova, LFA Wessels, ...
bioRxiv, 2023.06. 21.544805, 2023
2023
Abstract B022: Properties of T-cell-recognized neoantigens
P Kvistborg, MM Buuren, D Philips, N Rooij, A Velds, S Behjati, M Braber, ...
Cancer Immunology Research 7 (2_Supplement), B022-B022, 2019
2019
Benchmarking the Foreign Antigen Space of Human Malignancies
M Slagter, LF Fanchi, MM Buuren, A Velds, JJA Calis, PC Schouten, ...
Available at SSRN 3279415, 2018
2018
Breaking Insights
MD Wellenstein, SB Coffelt, DEM Duits, MH van Miltenburg, M Slagter, ...
The system can't perform the operation now. Try again later.
Articles 1–20